Skip to content

5-Amino-1MQ vs Alpha-GPC: side-by-side comparison

Other

5-Amino-1-methylquinolinium · 5A1MQ · 5-Amino-1MQ NNMT inhibitor

An orally-active small molecule that inhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in fat tissue in obesity. NNMT normally clears nicotinamide by methylating it (spending a methyl group from SAM); blocking it is intended to recycle more nicotinamide back into NAD+, raise cellular NAD+, and increase metabolic rate in fat cells. It sits on the same NAD+/methylation axis as NAD precursors but works from the opposite direction, reducing NAD breakdown rather than adding raw material.

1.0/10 natty
Full breakdown →
VS
Other

L-Alpha glycerylphosphorylcholine · Choline alfoscerate · sn-glycero-3-phosphocholine

A natural choline compound found in the brain that acts as an acetylcholine precursor. Alpha-GPC rapidly delivers choline across the blood-brain barrier, where it is used to make acetylcholine. It is sold as a nootropic/pre-workout supplement and, in several countries, prescribed as choline alfoscerate for cognitive decline.

1.0/10 natty
Full breakdown →

1 / 10 natty scale / 1

Same lane

Both sit in the same class, but they are pointed at different goals: 5-Amino-1MQ at cutting, recomposition, longevity, Alpha-GPC at performance, health.

The tape

Core ratings

The same three rulers every entry on the site is scored with, read head to head.

5-Amino-1MQAlpha-GPC
1.0

Natty scale

1 natural · 10 heavy

1.0
2.5

Effectiveness

Documented effect · of 5Δ0.5

3.0
1.5

Side-effect severity

Documented burden · of 5Δ0.5

2.0

Cost side

Body-load fingerprint

Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.

5-Amino-1MQAlpha-GPC

Systemic

Bars show strain at each one's typical protocol, not your dose. marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.

Logistics

The vitals

5-Amino-1MQAlpha-GPC
Other
Classmatch
Other
Oral
Routematch
Oral
50-150 mg/dayOnce daily, oral (with or without food)
Typical dose
300-630 mg/dayOnce daily (or pre-workout/pre-study); clinical dementia dosing is typically split 2-3x/day
~6.9 hours (rat, oral)
Half-life
~4-8 hours
8-12 weeks
Typical run
4-12 weeks
Research chemical
Legal status
OTC supplement
Unclear
WADA
Not prohibited

Benefit side

What each is for

Shared goals carry both dots; a goal with one dot belongs to that side alone.

5-Amino-1MQAlpha-GPC
CuttingRecompositionLongevityPerformanceHealth

Run for

Fat Loss / Metabolic RateThe headline use: NNMT inhibition raised metabolic rate and reduced fat mass in obese mice without appetite changes; extrapolated to a fat-loss/recomp aid.
Raising Intracellular NAD+Blocks the NNMT "leak" that clears nicotinamide, sparing it for NAD+ salvage, an alternative to loading NAD+ precursors.
Sirtuin / Longevity SupportHigher NAD+ supports sirtuin activity, tying it to the broader NAD+/longevity theme.
Oral ConvenienceUnlike injectable metabolic peptides, it is a small molecule taken orally.

Documented upside

  • Increases metabolic rate and reduces fat mass in animal models (no change in food intake)
  • Raises intracellular NAD+ by blocking its breakdown pathway
  • Spares SAM/methyl groups (opposite of the methylation burden from high-dose niacin)
  • Supports sirtuin activity via higher NAD+
  • Orally active small molecule: no injections
+1 more on the full page

Run for

Cognitive SupportUsed to support memory and cognition. A 2023 meta-analysis found alpha-GPC improved cognitive function and daily living in dementia of neurological origin, vascular dementia and Alzheimer's disease; an acute RCT in healthy men improved a cognitive (Stroop) test.
Choline Source for Nootropic StacksA go-to choline donor stacked with racetams (e.g. phenylpiracetam) and other nootropics to supply acetylcholine and blunt racetam 'choline headaches'.
Pre-Workout / Possible Acute GH BumpPopular in pre-workouts. An older study reported alpha-GPC augments the growth-hormone response to GHRH - but see the honest evidence flags: a 2024 exercise RCT found no GH or physical-performance effect.

Documented upside

  • Effective, bioavailable choline source that crosses the blood-brain barrier
  • Meta-analysis support for cognition in dementia populations
  • Acute cognitive (Stroop) improvement shown in healthy men
  • Pairs with racetams to reduce choline-depletion headaches
  • Generally well tolerated; FDA GRAS at up to ~196mg/day

The downsides

Side effects, aligned

Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.

5-Amino-1MQAlpha-GPC
Mood, sleep & CNS

None documented

Other documented effects

The exit

Hormonal fallout & recovery

What each does to your own hormone axis while on, and what leaving it costs.

5-Amino-1MQAlpha-GPC
Not required
PCT
Not required
While-on only
What sticks
While-on only

5-Amino-1MQ

Not hormonal. Does not affect the HPTA or testosterone. No PCT required.

Alpha-GPC

Not a hormone and does not affect the HPTA. No PCT required.

Read-out

How they separate

  1. 01

    Enhancement

    They land at almost the same point on the natty scale (1/10 vs 1/10): a similar distance beyond natural.

  2. 02

    Side-effect bill

    Alpha-GPC's documented side-effect severity is heavier (2/5 vs 1.5/5). The body-load fingerprint above shows where that weight actually lands.

  3. 03

    Coming off

    Neither requires PCT: both leave the natural testosterone axis running.

  4. 04

    Logistics

    typical runs are 8-12 weeks vs 4-12 weeks.

Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.